Women in the UK are far more likley to develop MS than men. A range of factors can also mean the symptoms of the disease can ...

I will while I can;’ that’s the motto that Alan Deacon lives by. Deacon, a former construction worker of twenty years started tripping over things ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

The Comal County Commissioners Court approved an event license agreement on Thursday to provide a rest stop in Sattler for an ...

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on th | Immunology ...

Every day, I see how unnecessary delays in treatment caused by cumbersome prior authorization barriers affect my patients.

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath.

Multiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve ...

A new study explores the use of tolerogenic dendritic cells (tolDCs) to restore immune balance in multiple sclerosis (MS) ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...